Ardelyx Inc (STU:41X)
€ 5.504 -0.062 (-1.11%) Market Cap: 1.30 Bil Enterprise Value: 1.23 Bil PE Ratio: 0 PB Ratio: 9.86 GF Score: 78/100

Ardelyx Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript

Feb 24, 2021 / 08:00PM GMT
Release Date Price: €5.55 (-0.61%)
Ami Fadia
SVB Leerink LLC, Research Division - MD of Biopharma & Generics and Senior Analyst

Good afternoon, everyone. Welcome to the next session on Ardelyx. As a reminder, I'm Ami Fadia. I cover biopharma and generics at SVB Leerink. And if you have any questions that you'd like me to ask during the conversation, please feel free to send it over through the dashboard.

It's my pleasure to have Mike Raab, who's the President and CEO of the company today with me. Mike, thank you for taking the time for doing this. Maybe if we could -- if I could ask you to just kick us off with giving an overview of the company, your lead product and the other therapeutic areas you're looking to explore?

Michael G. Raab
Ardelyx, Inc. - President, CEO & Director

Sure. Well, thank you, Ami. I really appreciate the invitation, and we've had a great day on Zoom meeting with a lot of a bunch of investors. So really appreciate the invite from you and SVB.

So we've created Ardelyx in 2007 to do exactly what we're about to demonstrate with 2 months and 5

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot